Physician profile
Mark Ombrellaro
NPI 1699793968
$11,548.85
in general payments reported to CMS, 2019-2025
11 companies · $3,333 in 2025
The $3,333 reported for 2025 was more than what 79% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,104 · 2020: $519 · 2021: $1,201 · 2022: $755 · 2023: $534 · 2024: $3,104 · 2025: $3,333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,174 · Travel and Lodging: $2,797.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,173.52 |
| Travel and Lodging | $2,797.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $5,268.95 | 2021-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis, Gore Tag Thoracic Endoprosthesis |
| Philips North America LLC | $2,828.87 | 2019-2022 | |
| Shockwave Medical, INC | $2,692.93 | 2019-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave E8 Peripher |
| Bolton Medical INC | $260.28 | 2020-2021 | |
| Surmodics, INC. | $167.12 | 2024 | Pounce Venous Thrombectomy System, Pounce Thrombectomy System, Sublime 014 Rx Pta Balloon Dilatation Catheter |
| Boston Scientific Corporation | $163.61 | 2024-2025 | General - Thrombectomy, Ekosonic, Seismiq Lithotrip_pi |
| Solventum Corporation | $80.52 | 2024 | Prevena, V.A.C.Instill |
| Becton, Dickinson and Company | $43.72 | 2025 | Rotarexs 6 F X 135 Cm |
| Medtronic Vascular, INC. | $25.71 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $17.14 | 2025 | Eliquis |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Ombrellaro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.